Prevalence of congenital heart disease

Julien I E Hoffman1, Samuel Kaplan, Richard R Liberthson

  • 1Department of Pediatrics, University of California, San Francisco, Calif 94143, USA. jhoffman@pedcard.ucsf.edu

Insights

Large numbers of adults with congenital heart disease are expected to survive, necessitating more adult cardiologists trained in managing complex heart conditions.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Statistics

Background:

  • Most patients with congenital heart disease now survive childhood.
  • The number of adult cardiologists needed for this growing population is unknown.

Purpose of the Study:

  • Estimate the number of patients with congenital heart disease (CHD) born since 1940.
  • Determine the number of survivors needing adult cardiology care.
  • Categorize CHD by management complexity.

Main Methods:

  • Estimated infant births with major CHD types using birth rates and incidence data.
  • Calculated survival numbers based on natural history and treatment outcomes.
  • Classified lesions as simple, moderate, or complex based on management expertise required.

Main Results:

  • Approximately 1 million simple, 500,000 moderate, and 500,000 complex CHD cases born 1940-2002 in the US.
  • Estimated 750,000 simple, 400,000 moderate, and 180,000 complex survivors with treatment.
  • Over 3 million individuals with bicuspid aortic valves alive; survival estimates vary with and without treatment.

Conclusions:

  • Significant numbers of adults with CHD will exist, whether treated or untreated.
  • Increased training for adult cardiologists is likely required, especially for moderate and complex congenital heart lesions.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...